The Progression of Alzheimer’s Disease from Limbic Regions to the Neocortex: Clinical, Radiological and Pathological Relationships

Alzheimer’s disease (AD) is characterised by the gradual accumulation of neurofibrillary pathology in selected regions of the brain. Earlier studies indicate that the accumulation of neurofibrillary tangles is associated both with decline in patient’s cognitive performance as well as with medial temporal lobe atrophy on CT scans. There are also indications that progression through the pathological stages of AD is associated with decline in cognitive functions. The results of this study indicate that progression of disease, especially beyond the boundaries of the limbic regions, is associated with marked decline in the cognitive performance of patients suffering from AD. However the clinical manifestations of early pathological stages are not so well defined. We also found that the atrophy of the medial temporal lobe on CT scans is related to the progression of pathology. Atrophy is most apparent when the disease reaches its isocortical stages and is not marked in the limbic stages of the disease. The additive effect of pathologies co-existing with AD is apparent in reduced cognitive scores, while the atrophy of limbic structures, as measured on CT scans, seems to be mainly attributable to AD-related pathology.

[1]  J. Wegiel,et al.  Neurofibrillary pathology — correlation with hippocampal formation atrophy in Alzheimer disease , 1996, Neurobiology of Aging.

[2]  P. Anslow,et al.  Association of atrophy of the medial temporal lobe with reduced blood flow in the posterior parietotemporal cortex in patients with a clinical and pathological diagnosis of Alzheimer's disease. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[3]  A. Smith,et al.  Rapidly progressing atrophy of medial temporal lobe in Alzheimer's disease , 1994, The Lancet.

[4]  A. Smith,et al.  Relative roles of plaques and tangles in the dementia of Alzheimer's disease: correlations using three sets of neuropathological criteria. , 1995, Dementia.

[5]  A. Smith,et al.  Use of structural imaging to study the progression of Alzheimer's disease. , 1996, British medical bulletin.

[6]  F. Pasquier,et al.  Medial temporal lobe atrophy in memory disorders , 1997, Journal of Neurology.

[7]  F. Huppert,et al.  CAMDEX: A Standardised Instrument for the Diagnosis of Mental Disorder in the Elderly with Special Reference to the Early Detection of Dementia , 1986, British Journal of Psychiatry.

[8]  G K Wilcock,et al.  Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[9]  A. Smith,et al.  Negative symptoms in schizophrenia: assessment of the effect of risperidone. , 1994 .

[10]  K. Jellinger,et al.  Neuropathological staging of Alzheimer lesions and intellectual status in Alzheimer's and Parkinson's disease patients , 1993, Neuroscience Letters.

[11]  H. Braak,et al.  Staging of Alzheimer-related cortical destruction. , 1997, International psychogeriatrics.

[12]  J. Wegiel,et al.  Atrophy of hippocampal formation subdivisions correlates with stage and duration of Alzheimer disease. , 1995, Dementia.

[13]  A. Smith,et al.  Hippocampal pathology reflects memory deficit and brain imaging measurements in Alzheimer's disease: clinicopathologic correlations using three sets of pathologic diagnostic criteria. , 1996, Dementia.

[14]  G. Salvioli,et al.  Validation of the full and short forms of the CAMDEX interview for diagnosing dementia. Cambridge Examination for Mental Disorders of the Elderly. , 1994, Dementia.

[15]  A. Smith,et al.  The Effects of Additional Pathology on the Cognitive Deficit in Alzheimer Disease , 1997, Journal of neuropathology and experimental neurology.

[16]  A. Smith,et al.  The diagnosis of Alzheimer's disease: a question of image? , 1994, The Journal of clinical psychiatry.

[17]  F. Gallyas,et al.  Silver staining of Alzheimer's neurofibrillary changes by means of physical development. , 1971, Acta morphologica Academiae Scientiarum Hungaricae.

[18]  A. Smith,et al.  Detection in life of confirmed Alzheimer's disease using a simple measurement of medial temporal lobe atrophy by computed tomography , 1992, The Lancet.

[19]  H. Braak,et al.  Staging of Alzheimer-type pathology: an interrater-intrarater study. , 1997, Dementia and geriatric cognitive disorders.

[20]  K. Jellinger,et al.  Clinicopathological analysis of dementia disorders in the elderly , 1990, Journal of the Neurological Sciences.